Back to Search Start Over

Estimation of intraglomerular pressure using invasive renal arterial pressure and flow velocity measurements in humans

Authors :
Gilbert W. M. Wijntjens
Liffert Vogt
Robbert J. de Winter
Peter M. van Brussel
Lennart van de Velde
John M. Karemaker
Berend E. Westerhof
Didier Collard
Bert-Jan H. van den Born
Jan J. Piek
Jim A. Reekers
Cardiology
Pulmonary medicine
ACS - Pulmonary hypertension & thrombosis
VU University medical center
Nephrology
Internal medicine
ACS - Atherosclerosis & ischemic syndromes
ACS - Diabetes & metabolism
ACS - Heart failure & arrhythmias
Multi-Modality Medical Imaging
Cardiovascular and Respiratory Physiology
Graduate School
Vascular Medicine
ACS - Microcirculation
Radiology and Nuclear Medicine
APH - Health Behaviors & Chronic Diseases
Public and occupational health
Source :
Journal of the American Society of Nephrology, 31(8), 1905-1914. American Society of Nephrology, Collard, D, van Brussel, P M, van de Velde, L, Wijntjens, G W M, Westerhof, B E, Karemaker, J M, Piek, J J, Reekers, J A, Vogt, L, de Winter, R J & van den Born, B-J H 2020, ' Estimation of Intraglomerular Pressure Using Invasive Renal Arterial Pressure and Flow Velocity Measurements in Humans ', Journal of the American Society of Nephrology, vol. 31, no. 8, pp. 1905-1914 . https://doi.org/10.1681/ASN.2019121272, J Am Soc Nephrol, Clinical journal of the American Society of Nephrology, 31(8), 1905-1914. American Society of Nephrology
Publication Year :
2020

Abstract

BACKGROUND: Glomerular hyperfiltration resulting from an elevated intraglomerular pressure (Pglom) is an important cause of CKD, but there is no feasible method to directly assess Pglom in humans. We developed a model to estimate Pglom in patients from combined renal arterial pressure and flow measurements. METHODS: We performed hemodynamic measurements in 34 patients undergoing renal or cardiac angiography under baseline conditions and during hyperemia induced by intrarenal dopamine infusion (30 μg/kg). For each participant during baseline and hyperemia, we fitted an adapted three-element Windkessel model that consisted of characteristic impedance, compliance, afferent resistance, and Pglom. RESULTS: We successfully analyzed data from 28 (82%) patients. Median age was 58 years (IQR, 52–65), median eGFR was 95 ml/min per 1.73 m(2) (IQR, 74–100) using the CKD-EPI formula, 30% had microalbuminuria, and 32% had diabetes. The model showed a mean Pglom of 48.0 mm Hg (SD=10.1) at baseline. Under hyperemia, flow increased by 88% (95% CI, 68% to 111%). This resulted in a 165% (95% CI, 79% to 294%) increase in afferent compliance and a 13.1-mm Hg (95% CI, 10.0 to 16.3) decrease in Pglom. In multiple linear regression analysis, diabetes (coefficient, 10.1; 95% CI, 5.1 to 15.1), BMI (0.99 per kg/m(2); 95% CI, 0.38 to 1.59), and renal perfusion pressure (0.42 per mm Hg; 95% CI, 0.25 to 0.59) were significantly positively associated with baseline Pglom. CONCLUSIONS: We constructed a model on the basis of proximal renal arterial pressure and flow velocity measurements that provides an overall estimate of glomerular pressure and afferent and efferent resistance in humans. The model provides a novel research technique to evaluate the hemodynamics of CKD on the basis of direct pressure and flow measurements. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Functional HEmodynamics in patients with and without Renal Artery stenosis (HERA), NL40795.018.12 at the Dutch national trial registry (toetsingonline.nl).

Details

Language :
English
ISSN :
10466673
Volume :
31
Issue :
8
Database :
OpenAIRE
Journal :
Journal of the American Society of Nephrology
Accession number :
edsair.doi.dedup.....89a61de49ccc629dd47d68972ca0a217
Full Text :
https://doi.org/10.1681/ASN.2019121272